What is the Efficiency When Comparing Active Sentry at Low IOP vs Ozil at High IOP?
1 other identifier
observational
36
1 country
1
Brief Summary
The objective is to assess the efficiency of the Active Sentry handpiece at low intraocular pressure (IOP) compared with the Ozil at high IOP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2023
CompletedStudy Start
First participant enrolled
May 16, 2023
CompletedFirst Posted
Study publicly available on registry
May 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 19, 2024
CompletedResults Posted
Study results publicly available
April 17, 2025
CompletedApril 17, 2025
April 1, 2025
11 months
May 3, 2023
March 4, 2025
April 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Total Aspiration Time
Day of surgery (Day 0)
Secondary Outcomes (3)
Total Fluid Volume
Day of surgery (Day 0)
Total Phaco Time
Day of surgery (Day 0)
Central Corneal Thickness
1 week postoperative
Other Outcomes (1)
Cumulative Dissipated Energy (CDE)
Day of surgery (Day 0)
Study Arms (2)
Active Sentry Handpiece
At low IOP settings
Ozil Handpiece
At high IOP settings
Interventions
Eligibility Criteria
Eligible test subjects will be 50 years of age or older and who are eligible to undergo sequential bilateral uncomplicated cataract surgery.
You may qualify if:
- Subjects are eligible for the study if they meet the following criteria:
- Note: Ocular criteria must be met in both eyes.
- Be eligible to undergo sequential bilateral uncomplicated cataract surgery.
- Undergo uneventful cataract surgery.
- Gender: Males and Females.
- Both eyes must have same grade of cataract.
- Willing and able to provide written informed consent for participation in the study.
- Willing and able to comply with scheduled visits and other study procedures.
You may not qualify if:
- Patient under 50 years of age.
- Unable to complete sequential bilateral cataract surgery in both eyes by the same surgeon (JS).
- Patient cataract surgery complicated by posterior capsular tear.
- Any disease state deemed by PI that increases risk of complicated cataract surgery (ie Pseudoexfoliation syndrome, zonular dehiscence, history of eye trauma, RA, prior refractive surgery, etc).
- The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.
- Pregnancy has a known effect on the stability of refractions and visual acuity. As such, subjects who become pregnant during the study will not be discontinued but their data may be excluded from analyses of effectiveness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cataract and Laser Institute of Southern Oregonlead
- Sengicollaborator
Study Sites (1)
Cataract & Laser Institute
Medford, Oregon, 97504, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Justin Spaulding
- Organization
- Cataract & Laser Institute
Study Officials
- PRINCIPAL INVESTIGATOR
Justin Spaulding, DO
Cataract and Laser Institute
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2023
First Posted
May 22, 2023
Study Start
May 16, 2023
Primary Completion
April 19, 2024
Study Completion
April 19, 2024
Last Updated
April 17, 2025
Results First Posted
April 17, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share